{
  "resourceType" : "EvidenceVariable",
  "id" : "PopulationQIRezidivKlinischeStudien",
  "meta" : {
    "profile" : ["https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-eligibility-criteria"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: EvidenceVariable PopulationQIRezidivKlinischeStudien</b></p><a name=\"PopulationQIRezidivKlinischeStudien\"> </a><a name=\"hcPopulationQIRezidivKlinischeStudien\"> </a><a name=\"PopulationQIRezidivKlinischeStudien-en-US\"> </a><p><b>url</b>: <a href=\"EvidenceVariable-PopulationQIRezidivKlinischeStudien.html\">EvidenceVariable Population CLL Rezidiv einschluss in klinische Studien</a></p><p><b>name</b>: PopulationQIRezidivKlinischeStudien</p><p><b>title</b>: Population CLL Rezidiv einschluss in klinische Studien</p><p><b>status</b>: Active</p><p><b>date</b>: 2025-01-16 09:02:23+0000</p><p><b>description</b>: </p><div><p>QI 4: Einschluss von Pat. mit Rezidiv in klinische Studien (modifiziert 2024)</p>\n</div><p><b>actual</b>: false</p><blockquote><p><b>characteristic</b></p><blockquote><p><b>definitionByCombination</b></p><p><b>code</b>: All of</p><blockquote><p><b>characteristic</b></p><h3>DefinitionByTypeAndValues</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 404684003}\">Clinical finding (finding)</span></td><td><span title=\"Codes:{http://snomed.info/sct 92814006}\">Chronic lymphoid leukaemia, disease</span></td></tr></table></blockquote><blockquote><p><b>characteristic</b></p><h3>DefinitionByTypeAndValues</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 404684003}\">Clinical finding (finding)</span></td><td><span title=\"Codes:{https://www.medizin.uni-greifswald.de/fhir/guideline/cll/CodeSystem/cll-v2 cllrlpstherapy}\">CLL-relapse under treatment</span></td></tr></table></blockquote></blockquote></blockquote></div>"
  },
  "url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationQIRezidivKlinischeStudien",
  "name" : "PopulationQIRezidivKlinischeStudien",
  "title" : "Population CLL Rezidiv einschluss in klinische Studien",
  "status" : "active",
  "date" : "2025-01-16T09:02:23+00:00",
  "description" : "QI 4: Einschluss von Pat. mit Rezidiv in klinische Studien (modifiziert 2024)",
  "actual" : false,
  "characteristic" : [{
    "definitionByCombination" : {
      "code" : "all-of",
      "characteristic" : [{
        "definitionByTypeAndValue" : {
          "type" : {
            "coding" : [{
              "system" : "http://snomed.info/sct",
              "code" : "404684003",
              "display" : "Clinical finding (finding)"
            }]
          },
          "valueCodeableConcept" : {
            "coding" : [{
              "system" : "http://snomed.info/sct",
              "code" : "92814006",
              "display" : "Chronic lymphoid leukaemia, disease"
            }]
          }
        }
      },
      {
        "definitionByTypeAndValue" : {
          "type" : {
            "coding" : [{
              "system" : "http://snomed.info/sct",
              "code" : "404684003",
              "display" : "Clinical finding (finding)"
            }]
          },
          "valueCodeableConcept" : {
            "coding" : [{
              "system" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/CodeSystem/cll-v2",
              "code" : "cllrlpstherapy",
              "display" : "CLL-relapse under treatment"
            }]
          }
        }
      }]
    }
  }]
}